See up to 3 months of PYXS. The 7-day demo opens the 1M and 3M ranges and puts PYXS on your watchlist.
Start 7-day demoLatest PYXS insider trades
About Pyxis Oncology, Inc. (PYXS)
Pyxis Oncology, Inc. is an SEC registrant, filing under CIK 0001782223, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
PYXS Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 3 | 20,235,766 | - |
| Grant or award | 3 | 2,800,006 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
PYXS insider transactions (Form 4)
2520 Form 4 filings on record, the earliest from Nov 27, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| GordonMD Global Investments LP - 10% Owner | Open-market purchase | Common Stock Purchase Warrant | 7,172,000 | - footnote F2 | - | |
| ||||||
| GordonMD Global Investments LP - 10% Owner | Open-market purchase | Common Stock, par value $0.001 per share ("Common Stock") | 5,517,000 | - footnote F2 | - | |
| GordonMD Global Investments LP - 10% Owner | Open-market purchase | Common Stock Purchase Warrant | 7,546,766 | - footnote F2 | - | |
| ||||||
 Thomas Civik - Officer | Grant or award | Stock Option (Right to Buy) | 2,503,050 | $0.00 | - | |
| Jakob Dupont - Director | Grant or award | Stock Option (Right to Buy) | 46,000 | $0.00 | - | |
| Thomas Civik - Officer | Grant or award | Stock Option (Right to Buy) | 250,956 | $0.00 | - | |
| Jakob Dupont | Option exercise | Common Stock | 35,000 | $1.60 | $56K | |
| Jakob Dupont | Open-market sale | Common Stock | 35,000 | $3.06 footnote F2,F3 | $107K | |
| Jakob Dupont | Option exercise | Stock Option (Right to Buy) | 35,000 | $0.00 | - | |
| ||||||
| Jakob Dupont | Grant or award | Stock Option (Right to Buy) | 45,867 | $0.00 | - | |
| Jitendra Wadhane - Officer | Grant or award | Common Stock | 109,461 footnote F1 | $0.00 | - | |
| Jitendra Wadhane - Officer | Grant or award | Stock Option (Right to Buy) | 262,635 | $0.00 | - | |
| ||||||
| John L. Flavin | Grant or award | Stock Option (Right to Buy) | 45,867 | $0.00 | - | |
| Michael A. Metzger | Grant or award | Stock Option (Right to Buy) | 45,867 | $0.00 | - | |
| Freda C. Lewis-Hall | Grant or award | Stock Option (Right to Buy) | 45,867 | $0.00 | - | |
| Darren S. Cline | Grant or award | Stock Option (Right to Buy) | 45,867 | $0.00 | - | |
| Rachel Humphrey | Grant or award | Stock Option (Right to Buy) | 45,867 | $0.00 | - | |
 Santhosh Palani | Grant or award | Stock Option (Right to Buy) | 45,867 | $0.00 | - | |
| Thomas Civik - Officer | Grant or award | Stock Option (Right to Buy) | 690,131 | $0.00 | - | |
| John L. Flavin | Grant or award | Stock Option (Right to Buy) | 36,979 | $0.98 | $36K | |
| Pamela Ann Connealy - Officer | Grant or award | Stock Option (Right to Buy) | 310,000 | $0.00 | - | |
| Jitendra Wadhane - Officer | Grant or award | Stock Option (Right to Buy) | 150,000 | $0.00 | - | |
| Lara Sullivan - Officer | Grant or award | Stock Option (Right to Buy) | 1,135,000 | $0.00 | - | |
| Pamela Ann Connealy - Officer | Open-market purchase | Common Stock | 5,450 | $2.00 | $11K | |
| Pamela Ann Connealy - Officer | Open-market purchase | Common Stock | 83,400 | $1.96 | $163K | |
Recent PYXS Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
PYXS insider trading FAQ
What is the latest insider trade for PYXS?
Pyxis Oncology, Inc. (PYXS) had 5 insider filings in the last 90 days, with the most recent on 2026-10-09. The full record for PYXS runs to 20 Form 4 filings, the earliest from 2024-11-27. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PYXS stock?
3 insider purchases of PYXS were filed in the last 90 days.
How many insiders are selling PYXS stock?
No insider sales of PYXS were filed in the last 90 days. 1 sale is on record for this company.
Where can I see PYXS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PYXS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - GordonMD Global Investments LP view on EDGAR
- - GordonMD Global Investments LP view on EDGAR
- - Thomas Civik view on EDGAR
- - Jakob Dupont view on EDGAR
- - Thomas Civik view on EDGAR
- - Jakob Dupont view on EDGAR
- - Jakob Dupont view on EDGAR
- - Jitendra Wadhane view on EDGAR
- - John L. Flavin view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where PYXS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PYXS with a 7-day demo
- PYXS on your watchlist
- Every PYXS Form 4 filing on record
- Up to 3 months of PYXS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
